How to "Turn Back the Clock" on this $174 Billion Tech Titan
Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.



Starbucks Climbing Back

by The Investment U Research Team

In a rare bit of truly positive earnings, Starbucks (Nasdaq: SBUX) announced that it earned $151 million in the third quarter compared to a loss of $6.7 million last year. This news sent the shares up over 10%.

Even as overall sales were down, Starbucks’ focus on efficiency and cost savings at ever level has helped the bottom line – combined with store closings of almost 700 locations. These changes, combined with others, have started trickling down into its results.

Starbucks has been aggressively looking to change its image on a couple fronts. Starbucks gave away free pastries earlier this week, and is looking at natural products as well.

It’s also been looking to its stronghold Seattle market to test new store concepts that involve adding beer and wine at Starbucks’ stores. And in other locations, removing the ubiquitous Starbucks branding to give the appearance of more affordable local coffee shops.

We’ve been watching this stock since the return of CEO and founder Howard Shultz earlier this year. And it looks like he’s starting to gain some real momentum in making positive changes.

If this keeps up, he’ll bring the company back to its roots and its stock glory days of almost $40 a share.

Symbols mentioned in this article: SBUX.

More on this topic (What's this?)
What the Crystal Ball Says About Starbucks (SBUX)
Rules For a Barista at Starbucks
SBUX looks like it might of Topped out.
Read more on Starbucks at Wikinvest
Related Investment U Articles:



McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Sign Up now and receive this Free report:

Contrarian Investing: Why It's Last Call for These Three Contrarian Investment Opportunities.




The Company Set to Dominate a $60 Billion-a-Year Market

$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.

The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."

Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.

Here's how you can claim your stake in the company before this cash infusion sends shares soaring.

Share Investment U:
  • email
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • Propeller
  • StumbleUpon
  • Technorati
  • Yahoo! Buzz
  • Reddit
  • NewsVine
  • SphereIt
  • Twitter

Comments

**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.

Check out our selection of daily Investment Research:

IU Blackboard IU Archives



Protect your purchasing power – invest in these foreign currencies and precious metals.

Recent Articles



Search Investment U





Platinum Services

Oxford Club
The Oxford Club
is an exclusive, global network of investors, who collectively participate in the pursuit of prosperity and wealth. The Club is renowned for its market-beating, tried-and-true investment principles.


White Cap The White Cap Report exclusively identifies companies, White Caps, which - by being among the earliest to gain traction - have secured dominant positions within untapped, billion-dollar markets.

A More Profitable Way to Play the Market







What Readers Are Saying…

"Always enjoy what you have to say, and learn something new (and useful) almost every time. Thanks again for your outstanding work." Jeff K.

"I just want to say a quick thank you to Alexander Green for not only his sage advise, but his reassuring words of encouragement that we all need right now." Bryan W.